Organon & Co.
NYSE:OGN
9.02 (USD) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 6,403 | 6,263 | 6,174 | 6,304 | 8,096 | 7,777 | 9,777 | 10,500 |
| Cost of Revenue
| 2,688 | 2,515 | 2,294 | 2,382 | 3,347 | 2,274 | 4,693 | 4,588 |
| Gross Profit
| 3,715 | 3,748 | 3,880 | 3,922 | 4,749 | 5,503 | 5,084 | 5,912 |
| Gross Profit Ratio
| 0.58 | 0.598 | 0.628 | 0.622 | 0.587 | 0.708 | 0.52 | 0.563 |
| Reseach & Development Expenses
| 469 | 528 | 471 | 443 | 304 | 220 | 365 | 355 |
| General & Administrative Expenses
| 0 | 1,682 | 1,449 | 1,432 | 1,468 | 1,181 | 1,691 | 1,929 |
| Selling & Marketing Expenses
| 0 | 209 | 255 | 236 | 198 | 262 | 322 | 356 |
| SG&A
| 1,760 | 1,893 | 1,704 | 1,668 | 1,666 | 1,443 | 2,013 | 2,285 |
| Other Expenses
| 0 | 0 | -15 | -279 | -29 | 7 | 142 | 0 |
| Operating Expenses
| 2,229 | 2,421 | 2,175 | 2,111 | 1,970 | 1,663 | 2,378 | 2,640 |
| Operating Income
| 1,486 | 1,327 | 1,478 | 1,619 | 2,849 | 3,847 | 2,706 | 3,272 |
| Operating Income Ratio
| 0.232 | 0.212 | 0.239 | 0.257 | 0.352 | 0.495 | 0.277 | 0.312 |
| Total Other Income Expenses Net
| -679 | -654 | -583 | -386 | -95 | -144 | 23 | -173 |
| Income Before Tax
| 807 | 673 | 1,122 | 1,529 | 2,680 | 3,696 | 2,729 | 3,099 |
| Income Before Tax Ratio
| 0.126 | 0.107 | 0.182 | 0.243 | 0.331 | 0.475 | 0.279 | 0.295 |
| Income Tax Expense
| -57 | -350 | 205 | 178 | 520 | 390 | 576 | 1,298 |
| Net Income
| 864 | 1,023 | 917 | 1,351 | 2,160 | 3,218 | 2,153 | 1,801 |
| Net Income Ratio
| 0.135 | 0.163 | 0.149 | 0.214 | 0.267 | 0.414 | 0.22 | 0.172 |
| EPS
| 3.36 | 4.01 | 3.61 | 5.33 | 8.52 | 12.71 | 8.51 | 7.11 |
| EPS Diluted
| 3.33 | 3.99 | 3.59 | 5.33 | 8.52 | 12.71 | 8.51 | 7.11 |
| EBITDA
| 1,613 | 1,436 | 1,690 | 1,814 | 2,989 | 4,180 | 4,379 | 5,079 |
| EBITDA Ratio
| 0.252 | 0.229 | 0.274 | 0.288 | 0.369 | 0.537 | 0.448 | 0.484 |